Research Article

Association of Polymorphisms in Toll-Like Receptors 4 and 9 with Autoimmune Thyroid Disease in Korean Pediatric Patients

Table 3

Allele frequencies of Toll-like receptor polymorphism in controls and patients with thyroid disease.

SNP allelesNormalAITDGDHD
2n = 366 (%)2n = 208 (%)2n = 120 (%)2n = 88 (%)

TLR1 (+742)C235 (64.2)126 (60.6)74 (61.7)52 (59.1)
rs4833095T131 (35.8)82 (39.4)46 (38.3)36 (40.9)
TLR2 (−16934)A187 (51.1)115 (55.3)65 (54.2)50 (56.8)
rs4696480T179 (48.9)93 (44.7)55 (45.8)38 (43.2)
TLR2 (intron1)A185 (50.5)112 (53.8)66 (55.0)46 (52.3)
rs1898830G181 (49.5)96 (46.2)54 (45.0)42 (47.7)
TLR2 (3UTR)G180 (49.2)116 (55.8)70 (58.3)46 (52.3)
rs7656411T186 (50.8)92 (44.2)50 (41.7)42 (47.7)
TLR3 (c.1243)A111 (30.3)59 (28.4)31 (25.8)28 (31.8)
rs3775291G255 (69.7)149 (71.6)89 (74.2)60 (68.2)
TLR3 (−7)A80 (21.9)49 (23.6)24 (20.0)25 (28.4)
rs3775296C286 (78.1)159 (76.4)96 (80.0)63 (71.6)
TLR4 (3UTR)C83 (22.7)49 (23.6)31 (25.8)18 (20.5)
rs11536889G283 (77.3)159 (76.4)89 (74.2)70 (79.5)
TLR4 (−1607)C103 (28.1)47 (22.6)25 (20.8)22 (25.0)
rs10759932T263 (71.9)161 (77.4)95 (79.2)66 (75.0)
TLR4 (intron1)C219 (59.8)135 (64.9)84 (70.0)a51 (58.0)
rs1927911T147 (40.2)73 (35.1)36 (30.0)37 (42.0)
CC-TLR5 (+1174)C362 (98.9)205 (98.6)118 (98.3)87 (98.9)
rs5744168T4 (1.1)3 (1.4)2 (1.7)1 (1.1)
CC-TLR6 (+745)C366 (100.0)208 (100.0)120 (100.0)88 (100.0)
rs5743810G0 (0.0)0 (0.0)0 (0.0)0 (0.0)
TLR6 (3UTR)C180 (49.2)117 (56.3)66 (55.0)51 (58.0)
rs2381289T186 (50.8)91 (43.7)54 (45.0)37 (42.0)
TLR9 (+2848)A150 (41.0)89 (42.8)50 (41.7)39 (44.3)
rs352140G216 (59.0)119 (57.2)70 (58.3)49 (55.7)
TLR9 (−1486)C152 (41.5)91 (43.8)51 (42.5)40 (45.5)
rs187084T214 (58.5)117 (56.2)69 (57.5)48 (54.5)
TLR9 (3UTR)C153 (41.8)90 (43.3)50 (41.7)40 (45.5)
rs352162T213 (58.2)118 (56.7)70 (58.3)48 (54.5)

SNP: single-nucleotide polymorphism; AITD: autoimmune thyroid diseases; HD: Hashimoto’s disease; GD: Graves’ disease; TLR: Toll-like receptor. Controls versus GD: aOR = 1.56 (1.0–2.4), .